An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer.
Toh
Chee-Keong
CK
Lee
Pyng
P
Chowbay
Balram
B
Goh
Jason W K
JW
Mancer
Kent
K
Tan
Puay-Hoon
PH
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010996:Pleural Effusion / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D011859:Radiography; D016896:Treatment Outcome
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride